CN Stock MarketDetailed Quotes
300255 Hebei Changshan Biochemical Pharmaceutical
- 20.48
- +0.66+3.33%
Trading Dec 27 11:21 CST
18.82BMarket Cap-22.29P/E (TTM)
20.80High19.70Low114.13KlotVolume19.85Open19.82Pre Close231.82MTurnover1.25%Turnover RatioLossP/E (Static)919.06MShares25.8852wk High10.35P/B18.76BFloat Cap7.5652wk Low23.78Limit Up915.91MShs Float25.88Historical High15.86Limit Down5.55%Amplitude1.83Historical Low--Dividend TTM20.31Avg Price48.69KlotAsk--Div YieldTTM100Lot Size59.98KlotBid
Hebei Changshan Biochemical Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -31.20%784.02M | -30.79%567.78M | -41.36%294.32M | -39.63%1.41B | -36.47%1.14B | -28.45%820.37M | -12.58%501.92M | -21.29%2.34B | -16.89%1.79B | -19.11%1.15B |
| Operating revenue | -31.20%784.02M | -30.79%567.78M | -41.36%294.32M | -39.63%1.41B | -36.47%1.14B | -28.45%820.37M | -12.58%501.92M | -21.29%2.34B | -16.89%1.79B | -19.11%1.15B |
| Other operating revenue | ---- | 10.57%5.17M | ---- | 37.31%13.25M | ---- | 3.76%4.68M | ---- | -64.66%9.65M | ---- | -68.35%4.51M |
| Total operating cost | -39.29%874.01M | -32.37%639.95M | -30.08%355.15M | -13.06%2.01B | -16.03%1.44B | -11.46%946.28M | -6.39%507.97M | -15.10%2.31B | -11.34%1.71B | -14.11%1.07B |
| Operating cost | -18.10%642.45M | -5.89%477.79M | -14.36%259.32M | -15.82%1.09B | -13.39%784.47M | -7.63%507.7M | 7.04%302.81M | 4.61%1.3B | 6.65%905.8M | -0.43%549.66M |
| Operating tax surcharges | -54.43%7.9M | -56.52%5.78M | -68.32%2.87M | -4.33%21.07M | 9.13%17.34M | 1.54%13.29M | -8.48%9.07M | -17.73%22.02M | -20.94%15.89M | -8.94%13.09M |
| Operating expense | -87.66%42.99M | -87.07%30.2M | -81.49%17.78M | -22.94%472.84M | -30.34%348.42M | -26.98%233.58M | -34.42%96.08M | -43.84%613.6M | -38.72%500.14M | -38.40%319.88M |
| Administration expense | -20.07%90.02M | -19.18%60.76M | -0.56%35.93M | 25.04%166.47M | 6.31%112.62M | 3.10%75.17M | -13.85%36.13M | 0.11%133.13M | 15.10%105.94M | 21.36%72.91M |
| Financial expense | -11.84%67.21M | -0.70%46.15M | -10.31%22.81M | -1.38%92.94M | 6.88%76.24M | 2.26%46.47M | 0.65%25.43M | 29.91%94.25M | 43.25%71.33M | 52.00%45.45M |
| -Interest expense (Financial expense) | -11.23%68.7M | -4.28%46.62M | -18.20%18.9M | 3.62%96.41M | 11.74%77.39M | 11.64%48.71M | 12.39%23.1M | 49.36%93.04M | 62.22%69.25M | 61.35%43.63M |
| -Interest Income (Financial expense) | -78.24%-2.53M | -44.18%-1.66M | 37.53%-385.86K | 7.65%-1.84M | -13.26%-1.42M | -48.21%-1.15M | -140.92%-617.66K | -54.16%-1.99M | -34.61%-1.25M | -5.56%-778.84K |
| Research and development | -76.69%23.44M | -72.48%19.29M | -57.26%16.44M | 9.52%158.82M | -12.88%100.56M | 3.42%70.07M | 6.40%38.45M | -3.73%145.01M | 8.48%115.42M | -1.18%67.75M |
| Credit Impairment Loss | 25.75%531.49K | -137.79%-467.41K | -153.06%-848.41K | -175.27%-25.92M | 145.06%422.67K | 498.73%1.24M | 213.53%1.6M | -231.20%-9.42M | -25.11%-938.1K | 70.88%-310.24K |
| Asset Impairment Loss | 101.15%1.39M | ---- | ---- | -5,380.77%-633.32M | ---121.35M | ---51.32M | ---- | ---11.56M | ---- | ---- |
| Other net revenue | 130.60%32.51M | 175.16%27.96M | -88.90%1.31M | -6,682.34%-631.55M | -1,631.00%-106.24M | -1,289.87%-37.21M | 575.77%11.79M | -187.74%-9.31M | -12.06%6.94M | -29.99%3.13M |
| Invest income | ---- | ---- | ---- | --7.02K | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset deal income | ---2.07K | ---2.07K | ---- | 152.67%7K | ---- | ---- | ---- | ---13.29K | ---13.29K | ---17.16K |
| Other revenue | 108.24%30.59M | 120.85%28.43M | -78.84%2.16M | 137.08%27.68M | 86.16%14.69M | 272.72%12.87M | 221.52%10.2M | -13.24%11.67M | -8.69%7.89M | -37.55%3.45M |
| Operating profit | 85.85%-57.48M | 72.90%-44.21M | -1,134.67%-59.52M | -6,095.95%-1.23B | -571.28%-406.28M | -301.66%-163.11M | -82.72%5.75M | -92.19%20.45M | -62.93%86.21M | -54.46%80.88M |
| Add:Non operating Income | 26,174.62%34.6M | 2,365.80%1.17M | 759.62%80.02K | -13.92%184.17K | 951.98%131.7K | 601.72%47.44K | 727.59%9.31K | 41.10%213.95K | -74.23%12.52K | -82.54%6.76K |
| Less:Non operating expense | 236.07%2.63M | 810.17%2.52M | 289.53%69.37K | 117.79%5.55M | -68.91%781.98K | -57.78%276.47K | -64.38%17.81K | 46.46%2.55M | 142.92%2.52M | 1,915.02%654.89K |
| Total profit | 93.73%-25.5M | 72.11%-45.55M | -1,136.02%-59.51M | -6,898.82%-1.23B | -586.15%-406.93M | -303.57%-163.34M | -82.72%5.74M | -93.04%18.12M | -63.85%83.7M | -54.83%80.24M |
| Less:Income tax cost | 119.19%2.3M | 163.02%1.35M | -51.88%2.5M | 106.77%16.46M | -153.36%-11.99M | -111.50%-2.15M | 18.38%5.19M | -72.69%7.96M | -15.31%22.47M | -13.96%18.67M |
| Net profit | 92.96%-27.81M | 70.90%-46.91M | -11,198.61%-62.01M | -12,389.70%-1.25B | -744.91%-394.94M | -361.83%-161.19M | -98.06%558.68K | -95.61%10.16M | -70.13%61.24M | -60.51%61.56M |
| Net profit from continuing operation | 92.96%-27.81M | 70.90%-46.91M | -11,198.61%-62.01M | -12,389.70%-1.25B | -744.91%-394.94M | -361.83%-161.19M | -98.06%558.68K | -95.61%10.16M | -70.13%61.24M | -60.51%61.56M |
| Less:Minority Profit | -431.00%-35.1M | 99.94%-3.16K | 91.44%-340.82K | -7.96%-7.94M | -9.25%-6.61M | -66.25%-5.31M | -398.18%-3.98M | -218.18%-7.36M | -197.52%-6.05M | -205.62%-3.2M |
| Net profit of parent company owners | 101.88%7.29M | 69.91%-46.9M | -1,457.82%-61.67M | -7,181.47%-1.24B | -677.10%-388.33M | -340.70%-155.88M | -84.68%4.54M | -92.50%17.51M | -67.51%67.29M | -58.74%64.76M |
| Earning per share | ||||||||||
| Basic earning per share | 102.38%0.01 | 70.59%-0.05 | -1,469.39%-0.0671 | -6,850.00%-1.35 | -700.00%-0.42 | -342.86%-0.17 | -84.54%0.0049 | -92.00%0.02 | -68.40%0.07 | -58.82%0.07 |
| Diluted earning per share | 102.38%0.01 | 70.59%-0.05 | -1,469.39%-0.0671 | -6,850.00%-1.35 | -700.00%-0.42 | -342.86%-0.17 | -84.54%0.0049 | -92.00%0.02 | -68.40%0.07 | -58.82%0.07 |
| Other composite income | 100.22%2K | 104.57%39.96K | 93.62%-43.4K | 63.68%-1.58M | 79.86%-928.53K | 75.63%-874.46K | 59.14%-680.35K | 64.78%-4.36M | 49.01%-4.61M | 29.24%-3.59M |
| Other composite income of parent company owners | 100.22%2K | 104.57%39.96K | 93.62%-43.4K | 63.68%-1.58M | 79.86%-928.53K | 75.63%-874.46K | 59.14%-680.35K | 64.78%-4.36M | 49.01%-4.61M | 29.24%-3.59M |
| Total composite income | 92.98%-27.8M | 71.08%-46.87M | -50,897.29%-62.05M | -21,647.93%-1.25B | -799.07%-395.87M | -379.54%-162.07M | -100.45%-121.67K | -97.35%5.8M | -71.11%56.63M | -61.57%57.98M |
| Total composite income of parent company owners | 101.87%7.29M | 70.10%-46.86M | -1,698.20%-61.71M | -9,538.15%-1.24B | -721.04%-389.26M | -356.25%-156.75M | -86.20%3.86M | -94.05%13.16M | -68.35%62.68M | -59.73%61.17M |
| Total composite income of minority owners | -431.00%-35.1M | 99.94%-3.16K | 91.44%-340.82K | -7.96%-7.94M | -9.25%-6.61M | -66.25%-5.31M | -398.18%-3.98M | -218.18%-7.36M | -197.52%-6.05M | -205.62%-3.2M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhongxi Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongxi Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
